This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Oncoarendi Therapeutics S.a.. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Marek Dziegielewski: Innovator in Therapeutic Applications
Introduction
Marek Dziegielewski is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of therapeutic compounds, particularly in the development of arginase inhibitors. With a total of 4 patents, his work is paving the way for new treatments in medicine.
Latest Patents
One of his latest patents focuses on arginase inhibitors and their therapeutic applications. This patent discloses small molecule therapeutic compounds that are potent inhibitors of arginase 1 and arginase 2 activity. Additionally, it includes pharmaceutical compositions comprising these compounds, along with methods for using them to treat or prevent diseases associated with arginase activity.
Career Highlights
Marek Dziegielewski is currently associated with Oncoarendi Therapeutics S.A., where he continues to innovate in the field of therapeutic applications. His expertise in developing arginase inhibitors has positioned him as a key player in the pharmaceutical industry.
Collaborations
Marek has collaborated with notable coworkers such as Roman Blaszczyk and Anna Gzik, contributing to the advancement of research and development in their field.
Conclusion
Marek Dziegielewski's work in developing arginase inhibitors showcases his commitment to advancing therapeutic applications. His contributions are significant in the ongoing quest for effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile